(19)
(11)
EP 0 425 536 A1
(12)
(43)
Date of publication:
08.05.1991
Bulletin 1991/19
(21)
Application number:
89907981.0
(22)
Date of filing:
14.06.1989
(51)
International Patent Classification (IPC):
C12N
15/
09
( . )
A61K
38/
17
( . )
A61K
39/
395
( . )
A61P
37/
04
( . )
C07K
14/
52
( . )
C12P
21/
02
( . )
A61K
38/
00
( . )
A61K
38/
20
( . )
A61P
7/
00
( . )
C07K
14/
00
( . )
C07K
14/
54
( . )
C12R
1/
865
( . )
(86)
International application number:
PCT/US1989/002599
(87)
International publication number:
WO 1990/001039
(
08.02.1990
Gazette 1990/04)
(84)
Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE
(30)
Priority:
20.07.1988
US 19880221699
(71)
Applicant:
IMMUNEX CORPORATION
Seattle Washington 98101 (US)
(72)
Inventors:
ANDERSON, Dirk, M.
Seattle, WA 98133 (US)
COSMAN, David, J.
Seattle, WA 98102 (US)
PRICE, Virginia, L.
Seattle, WA 98102 (US)
(74)
Representative:
Sheard, Andrew Gregory, et al
Kilburn & Strode 30, John Street
London WC1N 2DD
London WC1N 2DD (GB)
(54)
NONGLYCOSYLATED HUMAN INTERLEUKIN-3 COMPOSITIONS